Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

there was no such screening limit for whom the drug was approved, at least so far. ... he commented on his observation that the mabs were only relevant to 20% of the AD market (of 6.5 million, as I remember). I think this issue will be brought up when Anavex goes to the FDA for approval.

yes this was interesting. basically saying the mABs are only getting a small piece of the market while 273 is essentially an option for the entire alz market. Which of course is another reason for Accelerated Approval